top of page

IGT Statement on CMS Proposed Rule to Facilitate Value-based Purchasing Arrangements
FOR IMMEDIATE RELEASE CONTACT: Macey Kostbar msevcik@gene-therapies.org WASHINGTON, DC (June 18, 2020) – Below is a statement from the...

Patient Perspective: Susan Ruediger
Susan Ruediger is the founder and CEO of the CMT Research Foundation — a nonprofit organization with the single focus to expedite...


IGT Joins Axios to Host Webinar on Medical Research During a Crisis
Join Axios and IGT on May 4, 2020 at 12:30pm Eastern for a live, virtual event on essential medical research outside the scope of the...

FDA’s Dr. Peter Marks on Ways to Preserve Ongoing Medical Research During the Pandemic
By Jenn McNary, Patient Advocate, Founder of One Rare While most Americans are beginning to talk excitedly – albeit cautiously – about...


Patient Perspective: Seth Rotberg
Seth Rotberg of Boston, Massachusetts is a member of the IGT Patient Advocate Advisory Council, providing his expertise and experience to...

NEW INSTITUTE LAUNCHED TO ENSURE THE U.S. HEALTHCARE SYSTEM IS READY FOR GENE THERAPIES
FOR IMMEDIATE RELEASE CONTACT: Macey Kostbar msevcik@gene-therapies.org Industry leaders, patient advocates, researchers unite to...


Manufacturing: the next breakthrough in gene therapy
By Diane Blumenthal December 18, 2019 I never thought I’d see the day when words like “process,” “scale,” and “automation” would make...

FDA News Release: FDA Continues Strong Support of Innovation in Development of Gene Therapy Products
Guidances issued today provide regulatory clarity for product developers January 28, 2020 This is a pivotal time in the field of gene...

Progress in Gene Therapy Needs to Be Accelerated
By Erik Paulsen August 27, 2019 Throughout human history, transformative technological changes have faced varying degrees of opposition....
bottom of page